Australia markets close in 2 hours 6 minutes

Bellicum Pharmaceuticals, Inc. (BLCM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2800+0.1000 (+8.47%)
At close: 04:00PM EST
1.3400 +0.06 (+4.69%)
After hours: 04:50PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 10.16M
Enterprise value -35.99M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)21.29
Price/book (mrq)1.36
Enterprise value/revenue -23.99
Enterprise value/EBITDA 2.22

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 3-13.51%
S&P500 52-week change 3-7.75%
52-week high 32.2000
52-week low 30.6000
50-day moving average 30.9911
200-day moving average 31.1953

Share statistics

Avg vol (3-month) 340.88k
Avg vol (10-day) 364.94k
Shares outstanding 58.61M
Implied shares outstanding 6N/A
Float 87.06M
% held by insiders 14.41%
% held by institutions 131.44%
Shares short (12 Jan 2023) 482.15k
Short ratio (12 Jan 2023) 41.67
Short % of float (12 Jan 2023) 41.09%
Short % of shares outstanding (12 Jan 2023) 40.95%
Shares short (prior month 14 Dec 2022) 4108.21k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Feb 2020
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 305 Feb 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,649.33%

Management effectiveness

Return on assets (ttm)-57.64%
Return on equity (ttm)-103.45%

Income statement

Revenue (ttm)1.5M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)-80.00%
Gross profit (ttm)-17.38M
EBITDA -24.72M
Net income avi to common (ttm)-16.25M
Diluted EPS (ttm)0.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.76M
Total cash per share (mrq)3.34
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)5.44
Book value per share (mrq)0.87

Cash flow statement

Operating cash flow (ttm)-24.9M
Levered free cash flow (ttm)-22.88M